Wednesday, August 15, 2018
 
 
Company News: Page (1) of 1 - 06/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Oral Thrush Market Receives a Rapid Boost in Economy due to High Emerging Demands by Type and Treatment, Forecast to 2023

(June 12, 2018)


"Oral Thrush Market"
The Oral Thrush Market report titled “Oral Thrush Market Research Report- Global Forecast till 2023” is an expert analysis report which summarizes Market Scenario by major Indications, Drugs Class, Dosage and Products in-depth.

The Global Oral Thrush Market is increasing owing to the rising prevalence of oral candidiasis and the demand for effective medical care to treat the thrush.  Lifestyle has a significant influence on the physical and mental health of human being. Undoubtedly, today’s unhealthy, inactive or sedentary lifestyle is the main driving force behind the prevalence of Candida, further substantiating the market growth. 

Furthermore, various other risk factors for Oral Thrush, such as chronic diseases such as Cancer, diabetes along with the deadly HIV infection increase chances of getting infected with dubliniensis and C. geotrichium, increasing patent’s immunodeficiency.  Similarly, smokers hospitalized patients, and immune-compromised individuals are equally prone to develop the condition.

Over the past few years, there seems to be a significant rise in the initiatives undertaken by the health care professionals, insurance companies, and disease management companies to educate patients on the importance of oral care and treatments of the condition. All these factors commutatively provide impetus to the market growth. Resultantly, the oral thrush market is garnering a huge prominence and expansion, globally.

Considering the rapid market expansion in recent years, Market Research Future (MRFR) in its recently published study report asserts that the global Oral Thrush market is forecasted to reach USD 9.5 billion by 2023, posting approximately 4.4 % CAGR during the review period (2017-2023).

Availability of advanced antibacterial mouth rinses and oral hygiene products with improved quality and palatability is undoubtedly one of the predominant factors driving the market growth. The developing regions of Asia and the Middle East, present more growth opportunities for market players owing to the moderate competition in the market.

On the other hand, factors such as lack of awareness and the wrong diagnosis of the disease restrict the market growth, impacting the sales of oral health products. Nevertheless, the increase in the number of oral cancer patients and the use of chemotherapy along with the launch of new and better treatment medications are expected to lead the growth of the market.

Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4417 .

Global Oral Thrush Market - Key Players

Some of key players profiled in the report are Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer Inc., Wockhardt Ltd., Ranbaxy Laboratories Limited, Bristol Laboratories, Glenmark Pharmaceuticals, GlaxoSmithKline Plc., and others.

Global Oral Thrush Market - Industry/ Innovations/ Related News:

November 3, 2017 – Scientists at the University of Pittsburgh Schools of the Health Sciences, published their study, showing how the body recognizes when a harmless fungus in the mouth becomes a disease-causing infection. Identifying the mechanism by which the immune system first learns that the fungus Candida albicans, which causes oral thrush, has invaded the body, this study could eventually lead to better treatments for oral thrush.

Global Oral Thrush Market - Regional Analysis

North America leads the market owing to well-developed healthcare infrastructure and rising per capita healthcare expenditure. Europe holds the second largest market share. Increasing funding for research and huge patient population within the region facilitates the market growth. Asia Pacific is emerging as the fastest region for the market growth during the forecast period due to the presence of the developed economies like India and China within the region. According to the Indian Brand Equity Foundation in 2017, Indian healthcare sector is one of the fastest growing industries which is expected to advance at a CAGR of 22.87% during 2015-20 and reach USD 280 billion by 2020. On the other hand, Middle East and Africa holds the least market share, especially in the African region due to the stringent government policies and low per capita income. On the other hand, Middle East leads the market of the Middle East & Africa region, due to the presence of developed economies like Kuwait and Qatar along with huge healthcare expenditure.

Global Oral Thrush Market – Segments

The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, and end user.

Based on type, the market has been segmented as pseudomembranous, erythematous, hyperplastic, and others.

Based on diagnosis, the market has been segmented as examination, biopsy, endoscopy, and others.

Based on treatment, the market has been segmented as anti-fungal, immune-modulators, and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4417 .

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

List of Tables

Table 1 Global Oral Thrush Market, By Type, 2017-2023 (USD Million)

Table 2 Physical Examination for Oral Thrush Market, By Region, 2017-2023 (USD Million)

Table 3 Pseudomembranous For Oral Thrush Market, By Region 2017-2023 (USD

Million)

Table 4 Erythematous For Oral Thrush Market, By Region 2017-2023 (USD

Million)

List of Figures

Figure 1 Research Process

Figure 2 Market Dynamics for Global Oral Thrush Market

Figure 3 Global Oral Thrush Market, By Segment, 2016

Figure 4 Global Oral Thrush Success Market, By Region

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact

Company Name: Market Research FutureContact Person: Abhishek Sawant


Email: [email protected]
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com



Source: www.abnewswire.com


Page: 1


Related Keywords:Health & Medicine,News & Current Affairs,Pharmaceuticals & Biotech,U.S,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
  • Global Spinal Fusion Devices Market Expected to Reach USD 6.8 Billion By 2024: Zion Market Research

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  • ViewRay Announces Pricing of Public Offering of Common Stock
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines